- Report
- May 2024
- 140 Pages
Global
From €6138EUR$6,499USD£5,220GBP
- Report
- June 2024
- 200 Pages
Global
From €7508EUR$7,950USD£6,386GBP
- Report
- January 2022
- 60 Pages
Global
From €3730EUR$3,950USD£3,173GBP
- Report
- January 2022
- 60 Pages
Global
From €3730EUR$3,950USD£3,173GBP
- Drug Pipelines
- April 2024
- 70 Pages
Global
From €1417EUR$1,500USD£1,205GBP
- Report
- August 2022
Global
From €746EUR$790USD£635GBP
- Report
- November 2022
- 106 Pages
Global
From €1889EUR$2,000USD£1,607GBP
The Pertussis Drug market is a subset of the larger Respiratory Drugs market. Pertussis, also known as whooping cough, is a highly contagious bacterial infection of the respiratory system. Pertussis drugs are used to treat the infection and prevent its spread. These drugs are typically antibiotics, such as macrolides, tetracyclines, and sulfonamides. Vaccines are also used to prevent the infection.
The Pertussis Drug market is highly competitive, with many companies offering a variety of treatments. Major players in the market include GlaxoSmithKline, Merck & Co., Pfizer, Sanofi, and Novartis. Other companies, such as AstraZeneca, Bayer, and Johnson & Johnson, also offer products in the Pertussis Drug market. Show Less Read more